Home / Tag Archives: Boehringer Ingelheim

Tag Archives: Boehringer Ingelheim

Feed Subscription

EASD: Additional Evidence Showed ABASAGLAR® (insulin glargine) Provided Safety and Efficacy Similar to Lantus®

Secondary analyses evaluated ABASAGLAR® in patients previously treated with Lantus® insulin glargine

STOCKHOLM, Sept. 15, 2015 / PRNewswire — Data from secondary analyses of Phase III clinical trials showed that …

Read More »
Scroll To Top